Born: March 23, 1942 in Miami, FL
Education: B.S. in Engineering from the U.S. Naval Academy; MBA from Stanford University.
Career Path: Robin Bellas is a general partner with Morgenthaler. Prior to joining the firm in 1983, Robin was General Manager of the Electronics Division of Harshaw Corp., until its sale to Kaiser. He served as Director of Marketing & Sales of Acurex Corp. until 1980. Between 1973 and 1977, he was Vice President of Marketing & Sales at SHM Nuclear Corp. (acquired by EMI Medical). Earlier, he served as a line officer on nuclear submarines. He is a
Venture Focus: Telecom, Healthcare
Investments: A-MED, Ancile Pharmaceuticals, Calyx Therpeutics, Integrated Vascular Systems, Pointshare, Protogene, Satiety, Third Millenium Healthcare Services, Wave7 Optics, Arbor Health Care (acquired by Extendicare), Athena Neurosciences (acquired by Elan), CardioThoracic Systems (acquired by Guidant), Embol-X, Executone, The Liposome Co., LuMed, Managed Health Network (acquired by Foundation Health), Medaphis Corp., National Medical Diagnostics (acquired by GE Medical), Perclose (acquired by Abbott Labs), Sequana Therapeutics (acquired by Arris Pharmaceuticals), Surgical Health (acquired by HealthSouth Rehab), Thermage, Verifone (acquired by Hewlett Packard), and Vical.
Other affiliations: Past Director of the Western Association of Venture Capitalists (WAVC), and currently serves as a Director of the Stanford Business School Trust.
Greatest Accomplishment: Helping to build the franchise at Morgenthaler by financing several billion dollar companies. And, helping to defeat the Soviets during the Cold War.
Biggest Mistake: Turing down the Series B at Idec, now a $10 billion company.
If you weren’t a VC, you’d be a?Retired Navy submarine Admiral windsurfing on Oahu.
Pet Peeve: CEOs who don’t set clear, measurable goals and objectives.
Did You Know? Was a two-time National Championship oarsman on the Naval Academy crew team.
Are we missing something?